Myovant Sciences (NYSE:MYOV) reported its Q3 earnings results on Wednesday, January 26, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Myovant Sciences missed estimated earnings by 13.33%, reporting an EPS of $-0.68 versus an estimate of $-0.6, which surprised analysts.
Revenue was up $53.06 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.15, which was followed by a 1.31% drop in the share price the next day.
Here's a look at Myovant Sciences's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.38 | -0.33 | -0.99 | -0.85 |
| EPS Actual | -0.23 | -0.67 | -0.89 | -0.82 |
| Revenue Estimate | 71.40M | 57.05M | 24.63M | 2.17M |
| Revenue Actual | 77.90M | 41.06M | 24.61M | 1.38M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
